Unlocking billions of value for life science companies with medical analytics - Dipanwita Das, Sorcero
Description
We sat down with Sorcero’s extraordinary Dipanwita Das to talk about working with T-1 Pharma and early-stage biotechs, building the largest open-access scientific literature database, 10x-ing productivity, and surfacing strategic signals with the medical analytics platform powered by the latest advances in NLU.
Dipanwita Das is the CEO and founder of Sorcero. Sorcero is on a mission to improve patient outcomes by empowering life sciences experts to dramatically increase productivity, decrease literature monitoring time, and increase tracking of portfolio products.
Sorcero raised $16M and is backed by City Rock Ventures Partners, Harmonix Fund, Rackhouse, Mighty Capital, Leawood VC, Castor Ventures, and Worldquant Ventures among others.
0:00 - Medical analytics platform for life science companies.
09:13 - Case studies: Increasing productivity by 10x, reducing costs, unifying internal and external data, surfacing strategic signals
14:00 - Getting to insights faster with the help of AI
18:24 - AI technologies powering Sorcero: LLMs, Summarization, MLOps
33:45 - Dipanwita’s pass to founding Sorcero: starting a consulting firm, falling in love with healthcare
38:01 - Benefits of reading science fiction
40:40 - Building the team for Sorcero as a recent immigrant, without a huge network
45:52 - 0-to-1 people vs 1-to-100 people
51:00 - Building a culture of mastery, humility, collaboration
56:30 - The future of medical analytics at Life science companies / medical affairs transformation
Linkedin: https://www.linkedin.com/in/dipanwitadas/
Twitter: https://twitter.com/dipanwita_d
Turing test of summarization: https://www.sorcero.com/blog/ai-experiment
Sorcero and OurResearch Partner to Bring Open Access Scientific and Medical Content and Patient-Centric Publication Metrics to Life Sciences: https://www.prweb.com/releases/sorcero_and_ourresearch_partner_to_bring_open_access_scientific_and_medical_content_and_patient_centric_publication_metrics_to_life_sciences/prweb19134162.htm
At forward we invest in visionary leaders who move the world forward. Learn more at https://dawn-gv.com
Contact us at forward@dawn-gv.com
United States
